190 related articles for article (PubMed ID: 24862514)
1. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
5. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
Robertson SA; Lascelles BD; Taylor PM; Sear JW
J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
[TBL] [Abstract][Full Text] [Related]
9. Effects of epidurally administered morphine or buprenorphine on the thermal threshold in cats.
Pypendop BH; Siao KT; Pascoe PJ; Ilkiw JE
Am J Vet Res; 2008 Aug; 69(8):983-7. PubMed ID: 18672960
[TBL] [Abstract][Full Text] [Related]
10. Dose-related antinociceptive effects of intravenous buprenorphine in cats.
Steagall PV; Mantovani FB; Taylor PM; Dixon MJ; Luna SP
Vet J; 2009 Nov; 182(2):203-9. PubMed ID: 18691917
[TBL] [Abstract][Full Text] [Related]
11. Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats.
Steagall PV; Carnicelli P; Taylor PM; Luna SP; Dixon M; Ferreira TH
J Vet Pharmacol Ther; 2006 Dec; 29(6):531-7. PubMed ID: 17083457
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oxymorphone in cats.
Siao KT; Pypendop BH; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2011 Dec; 34(6):594-8. PubMed ID: 21323677
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats.
Gulledge BM; Messenger KM; Cornell KK; Lindell H; Schmiedt CW
J Feline Med Surg; 2018 Apr; 20(4):312-318. PubMed ID: 28569590
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
Krotscheck U; Boothe DM; Little AA
Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of analgesic effect and absorption of buprenorphine after buccal administration in cats with oral disease.
Stathopoulou TR; Kouki M; Pypendop BH; Johnston A; Papadimitriou S; Pelligand L
J Feline Med Surg; 2018 Aug; 20(8):704-710. PubMed ID: 28895776
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
Slingsby LS; Murrell JC; Taylor PM
Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
[TBL] [Abstract][Full Text] [Related]
18. Impact of the blood sampling site on time-concentration drug profiles following intravenous or buccal drug administration.
Hedges AR; Pypendop BH; Shilo Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Apr; 37(2):145-50. PubMed ID: 24745064
[TBL] [Abstract][Full Text] [Related]
19. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD
J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.
Love EJ; Pelligand L; Taylor PM; Murrell JC; Sear JW
Vet Anaesth Analg; 2015 Jan; 42(1):17-29. PubMed ID: 24735059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
